comparemela.com

Latest Breaking News On - Unicorn enterprises - Page 1 : comparemela.com

China leads acceleration of global digital economy

&copy; Provided by Xinhua BEIJING, July 6 (Xinhua) China has witnessed a significant increase in the size of its digital economy over the past seven year

City ofUnited kingdomBaja californiaMacau generalSan franciscoUnited statesMei hongAhmed abdel hafezAbu dhabiInformation technologyData drives developmentChinese academy of sciencesMunicipal bureau of economyGlobal digital economy conferenceChinese academyAbdel hafez

China CDE Approved First Universal CAR-T IND !

/PRNewswire/ On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T).

Immunotherapy excellence centerNational intellectual property management enterpriseChina national drug administration review centerUnicorn enterprisesInnovation talents program of jiangsu provinceNational scienceBioheng biotech co ltdHillhouse venture capitalDecheng capitalOctagon capitalJiangsu provinceNanjing high level entrepreneurial talent planNanjing expert studioNanjing bioheng biotech co

China CDE Approved First Universal CAR-T IND !

/PRNewswire/ On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T).

Immunotherapy excellence centerNational intellectual property management enterpriseChina national drug administration review centerUnicorn enterprisesInnovation talents program of jiangsu provinceNational scienceBioheng biotech co ltdHillhouse venture capitalDecheng capitalOctagon capitalJiangsu provinceNanjing high level entrepreneurial talent planNanjing expert studioNanjing bioheng biotech co

CTB001, Bioheng auto CAR - T Product, received Orphan Drug Designation (ODD) from the U S FDA

/PRNewswire/ Recently, Nanjing Bioheng Biotech Co., Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell.

United statesNational intellectual property management enterpriseUnicorn enterprisesDrug administrationNational scienceImmunotherapy excellence centerInnovation talents program of jiangsu provinceOffice of orphan products developmentBioheng biotech co ltdOrphan drug designationBioheng exploredPrescription drug user fee actOrphan products developmentHillhouse venture capitalDecheng capitalOctagon capital

vimarsana © 2020. All Rights Reserved.